Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Guidance for COVID-19: Prevention, Control, Diagnosis and Management
    Guidance for COVID-19: Prevention, Control, Diagnosis and Management
    Guidance for COVID-19: Prevention, Control, Diagnosis and Management
    Ebook166 pages1 hour

    Guidance for COVID-19: Prevention, Control, Diagnosis and Management

    By Royal Collins Publishing Company

    ()

    Read preview

    About this ebook

    This book is a guide for the prevention and control measures issued by the Chinese Health Commission during the novel coronavirus pneumonia outbreak that has led to the global Covid-19 pandemic. With the guidance of this authoritative text, the number of cases in China has decreased from 83,386 to 2,000, and a complete victory in prevention and control will soon be achieved. This book is suitable for professionals who are a part of the prevention and control of the plague, and for any readers who are concerned about their lives and the lives of their families and communities. May God bless the world and bring us vict
    LanguageEnglish
    PublisherRoyal Collins Publishing Company
    Release dateJun 1, 2020
    ISBN9781487804671
    Guidance for COVID-19: Prevention, Control, Diagnosis and Management

    Related to Guidance for COVID-19

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Why Eggs Are Good For Your Heart

      Nov 27, 2022

      Why Eggs Are Good For Your Heart
      1 min read

    • Article

      The Philosopher Who Says We Should Play God: Why ethical objections to interfering with nature are too late.

      Sep 3, 2015

      Australian bioethicist Julian Savulescu has a knack for provocation. Take human cloning. He says most of us would readily accept it if it benefited us. As for eugenics—creating smarter, stronger, more beautiful babies—he believes we have an ethical o

      11 min read

    • Article

      PEOPLE & POINTS

      Feb 20, 2020

      Li Lanjuan, a famous epidemiologist and member of the expert panel appointed by the Chinese Government, has made great progress in helping prevent and control the outbreak of the novel coronavirus pneumonia. Recently, her team succeeded in the treatm

      4 min read

    • Article

      COVID-19: Risk Assessment & Mitigation Strategy

      Nov 6, 2020

      Aster DM Healthcare has been at the epicentre of managing COVID-19 pandemic in India and Gulf Cooperation Council countries ever since the pandemic hit in mid-March. This paper is a fascinating organisational case study and report about how Aster DM

      11 min read

    • Article

      Concerted Efforts

      Feb 6, 2020

      Since the outbreak of the novel coronavirus (2019-nCoV), China has carried out close cooperation with international organizations and governments on many fronts, including data-sharing, information notification and citizen evacuation, to curb the vir

      4 min read

    • Article

      A Timely Response

      Apr 16, 2020

      The COVID-19 pandemic is a major public health emergency that has spread the fastest, caused the most extensive infections and been the hardest to contain since the founding of the People’s Republic of China in 1949. With joint efforts of the whole n

      5 min read

    • Article

      Chronicle of An Epic War

      Jun 18, 2020

      On June 7, the State Council Information Office issued a white paper on China’s battle against the novel coronavirus disease (COVID-19). Titled Fighting COVID-19: China in Action, the white paper gives a detailed, chronological account of the governm

      5 min read

    • Article

      An All-out War

      Feb 6, 2020

      An All-out War
      8 min read

    • Article

      Looking Beyond The Coronavirus

      Mar 19, 2020

      The author is an op-ed contributor to Beijing Review and senior partner emeritus at McKinsey & Company The novel coronavirus is dominating the 2020 global news cycle. The virus has reached more than 110 countries and regions, killed over 4,000 people

      3 min read

    • Article

      An Injection of Hope

      May 13, 2021

      The drive to effectively vaccinate the world’s population against COVID-19 has seen many other important vaccines lose their place in the public spotlight. However, one particular group of vaccines was back in the news in April after the Chinese Acad

      5 min read

    • Article

      Growing Pains

      May 5, 2022

      Making the daily rounds, attending consultations, sharing the latest updates during expert discussions… Zhang Wenhong, head of the Shanghai COVID-19 medical expert team, has been tied up with work. Though Shanghai has seen a declining number of infec

      4 min read

    • Article

      Viral Signs

      Mar 9, 2020

      Viral Signs
      7 min read

    • Article

      Safeguarding Health

      Jul 7, 2022

      Malaria used to be a serious threat to people’s health and lives in China. In the 1940s, there were approximately 30 million cases every year, leading to 30,000 deaths annually. However, through decadelong efforts, no domestic cases have been reporte

      5 min read

    • Article

      Why Scientific Cooperation Is a Must

      Mar 12, 2020

      China’s battle against the novel coronavirus disease (COVID-19) has now seen progress. While health workers deserve the most credit for their contributions, the community of scientists has also provided powerful support. President Xi Jinping, who ins

      1 min read

    • Article

      On Guard, En Garde!

      Apr 7, 2022

      At a press conference on March 29, Liu Renyuan, Deputy Secretary General of the municipal government of Changchun, capital of Jilin Province, expressed apologies for the grocery shortages related to lockdowns, and more specifically the closure of two

      4 min read

    • Article

      Portrait Of A Pandemic

      Jan 19, 2023

      Portrait Of A Pandemic
      6 min read

    • Article

      What China Can Offer In Covid-19 Containment

      Mar 5, 2020

      More than a month of intense prevention and control measures have borne fruit in China: Both new confirmed and suspected cases of the novel coronavirus disease (COVID-19) are dropping, so is the fatality rate and the number of cured and discharged pa

      2 min read

    • Article

      PEOPLE & POINTS

      Feb 6, 2020

      Zhong Nanshan, born in 1936, is a specialist on respiratory diseases. Heading a National Health Commission expert panel, he is conducting research on the novel coronavirus. He was the first to report that the virus can transmit between people on Janu

      3 min read

    • Article

      On the Frontline

      Apr 2, 2020

      On the Frontline
      10 min read

    • Article

      Chinese Leadership Hails 'Decisive Victory' Over Pandemic In Ending Zero-Covid Policy

      Feb 17, 2023

      Chinese leaders have hailed a "decisive victory" over the Covid pandemic and called the country's successful exit from zero-Covid policy a "miracle". The conclusion was made public at a Politburo Standing Committee meeting chaired by President Xi Jin

      2 min read

    • Article

      Nature’s Remedy

      Jul 14, 2022

      Shanghan Zabing Lun, or Treatise on Febrile and Miscellaneous Diseases, is a traditional Chinese medicine (TCM) classic compiled by Chinese pharmacologist and physician Zhang Zhongjing in the late Han Dynasty (202 B.C.-A.D. 220). The work is amongst

      4 min read

    • Article

      Continuing The Global Fight

      May 28, 2020

      China will continue international cooperation in the global battle against the novel coronavirus disease (COVID-19), provide foreign assistance and make its domestically developed vaccine a global public good when available. President Xi Jinping made

      5 min read

    Reviews for Guidance for COVID-19

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Guidance for COVID-19 - Royal Collins Publishing Company

      GUIDANCE FOR COVID-19

      This book is a guide for the prevention and control measures issued by the Chinese Health Commission during the novel coronavirus pneumonia outbreak that has led to the global Covid-19 pandemic. With the guidance of this authoritative text, the number of cases in China has decreased from 83,386 to 2,000, and a complete victory in prevention and control will soon be achieved.

      This book is suitable for professionals who are a part of the prevention and control of the plague, and for any readers who are concerned about their lives and the lives of their families and communities.

      May God bless the world and bring us victory!

      The National Health Commission (NHC) of the People’s Republic of China is a cabinet-level executive department of the State Council which is responsible for formulating health policies in Mainland China. It was formed on 19 March 2018. The ministry is headquartered in Beijing. The commission is led by a Minister of cabinet rank in the state council.

      www.royalcollins.com

      Guidance for COVID-19: Prevention, Control, Diagnosis and Management

      First published in 2020 by Royal Collins Publishing Group Inc.

      Groupe Publication Royal Collins Inc.

      BKM ROYALCOLLINS PUBLISHERS PRIVATE LIMITED

      Headquarters: 550-555 boul. René-Lévesque O Montréal (Québec) H2Z1B1 Canada

      India office: 805 Hemkunt House, 8th Floor, Rajendra Place, New Delhi 110 008

      Original Edition © People’s Medical Publishing House

      Copyright © Royal Collins Publishing Group Inc.

      Groupe Publication Royal Collins Inc.

      BKM ROYALCOLLINS PUBLISHERS PRIVATE LIMITED

      All rights reserved. Without limiting the rights under copyright reserved above, no part of this publication may be reproduced, stored in or introduced into a retrieval system, or transmitted in any form or by any means (electronic, mechanical, photocopying, recording or otherwise), without the prior written permission of both the copyright owner and the above publisher of this book.

      ISBN: 978-1-4878-0456-5 (paperback)

      ISBN: 978-1-4878-0467-1 (ebook)

      To find out more about our publications, please visit www.royalcollins.com

      Preface

      On December 29, 2019, a hospital in Wuhan, Hubei Province, China reported an outbreak of severe unexplained viral pneumonia. The Chinese government timely notified World Health Organization (WHO) about the outbreak after verification. On January 8, 2020, the pathogen of this outbreak was identified as the novel coronavirus 2019 (2019-nCoV), and its gene sequence was quickly submitted to WHO. On January 30, WHO declared the outbreak of the novel coronavirus pneumonia (NCP) as a public health emergency of international concern (PHEIC). On February 12, 2020, International Committee on Taxonomy of Viruses (ICTV) declared that 2019-nCoV was officially named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and on the same day, WHO declared the disease caused by SARS-CoV-2 was officially named as corona virus disease 2019 (COVID-19).

      The Chinese government gives top priority to the safety of people’s life and health thus has taken the prevention and control of COVID-19 epidemic as the most important work at present. To control the COVID-19 outbreak, the National Health Commission of the People’s Republic of China, along with the National Administration of Traditional Chinese Medicine and some other relative organizations, have organized experts to timely issue and update the guidelines for the COVID-19 diagnosis, treatment, prevention, and control. The guidelines were written based on the study, analysis and summary of the treatment of previous COVID-19 cases, and are used to guide medical staff and public health workers in China to better understand, prevent and treat the COVID-19.

      In order to truthfully and objectively share China’s COVID-19 diagnosis, treatment, prevention, and control experience with the world, we have translated the latest Chinese guidelines and their relevant interpretations in this book. We hope this book can provide references for other countries affected by the COVID-19, and also promote the experience exchange and cooperation in disease prevention, control, diagnosis and management, thus promote the development of global health together.

      On behalf of the compilation and translation board of this book, we especially acknowledge Prof. Jinling TANG (from Guangzhou Women and Children’s Medical Center) and Prof. Huaqing WANG (from Chinese Center for Disease Control and Prevention) for their help and support for the publication of this book.

      Xiaofeng LIANG, Zijian FENG, and Liming LI

      Compilation and Translation Board

      Translators in Chief

      Xiaofeng LIANG, Chinese Preventive Medicine Association, Beijing, China

      Zijian FENG, Chinese Center for Disease Control and Prevention, Beijing, China

      Liming LI, Peking University, Beijing, China

      Committee Members

      Zhenqiang BI, Shandong Center for Disease Control and Prevention, Jinan, China

      Qingwu JIANG, Fudan University, Shanghai, China

      Peng WANG, Chinese Preventive Medicine Association, Beijing, China

      Yu JIANG, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

      Authors of Chapters of Development and Revisions of Plans/Guidelines

      Rongmeng JIANG, Beijing Ditan Hospital, Capital Medical University, Beijing, China

      Liping WANG, Chinese Center for Disease Control and Prevention, Beijing, China

      Peng WANG, Chinese Preventive Medicine Association, Beijing, China

      Translators

      Yu JIANG, Yongle ZHAN, Yawen WANG, Mingyu SI, Jingwen ZHANG, Mingshuang LI, Yunli CHEN, Yingjie SHI, Xuan LIU, Hexin YUE, Ao JING, Tianchen LV, Yaohan MENG, Yimin QU, Yahui FENG, Baohu YAN, Sansan WU, Shuya CAI, and Peng XUE

      School of Public Health, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

      Contents

      Preface

      Compilation and Translation Board

      Part OneDiagnosis and Treatment Plan of Corona Virus Disease 2019

      Chapter 1Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Tentative Sixth Edition)

      Chapter 2Interpretation of the Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Tentative Fifth Revised Edition)

      Chapter 3Interpretation of the Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Tentative Sixth Edition)

      Chapter 4Development and Revisions of the Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Tentative First to Sixth Editions)

      Part TwoPrevention and Control Plan of Corona Virus Disease 2019

      Chapter 1Prevention and Control Plan of Corona Virus Disease 2019

      (Fourth Edition)

      Chapter 2Interpretation of the Prevention and Control Plan of Corona Virus Disease 2019

      (Fourth Edition)

      Chapter 3Development and Revisions of the Prevention and Control Plan of Corona Virus Disease 2019

      (First to Fourth Editions)

      Part ThreeGuidelines for Prevention and Control of 2019-nCoV

      Chapter 1Guidelines for Prevention and Control of 2019-nCoV

      (First Edition)

      Chapter 2Interpretation of the Guidelines for Prevention and Control of 2019-nCoV

      (First Edition)

      PART ONE

      Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Source: National Health Commission (NHC) of the PRC, General Office; National Administration of Traditional Chinese Medicine of the PRC, General Office)

      CHAPTER 1

      Diagnosis and Treatment Plan of Corona Virus Disease 2019

      (Tentative Sixth Edition)

      Since December 2019, an increasing number of cases of novel coronavirus pneumonia (NCP) have been diagnosed in Wuhan, Hubei Province. With the spreading of the epidemic, cases (officially named as Corona Virus Disease 2019 [COVID-19] by WHO) have also been reported in other regions of China and abroad. COVID-19 was urgently classified, by the Law of the People’s Republic of China on the Prevention and Treatment of Infectious Diseases as Class B communicable diseases, and is managed as Class A communicable diseases. With the in-depth understanding and accumulation of diagnosis and treatment experience of COVID-19, the Diagnosis and Treatment Plan of Corona Virus Disease 2019 (the Tentative Fifth Revised Edition) was revised and formed the current tentative sixth edition.

      1 Pathogenic Characteristics

      The novel coronavirus 2019 (2019-nCoV, officially named as severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] by ICTV) belongs to the genus β, with envelope, round or elliptic and often pleomorphic form, and 60–140 nm in diameter. The virus genetically differs considerably from those of SARSr-CoV and MERSr-CoV. Current studies show that the homology between 2019-nCoV and bat-SARS-like coronavirus (bat-SL-CoVZC45) is over 85%. When cultured in vitro, 2019-nCoV can be found in human respiratory epithelial cells after about 96 hours, while it takes about 6 days to isolate and culture Vero E6 and Huh-7 cell lines.

      Knowledge on the physical and chemical characteristics of coronaviruses is mainly derived from the study of SARSr-CoV and MERSr-CoV. Coronaviruses are sensitive to ultraviolet rays and heat, and can be effectively inactivated by heating at 56°C for 30 min and lipid solvents such as ether, 75% ethanol, chlorine-containing disinfectant, peroxyacetic acid and chloroform except chlorhexidine.

      2 Epidemiological Characteristics

      2.1 Source of Infection

      At present, the major source of infection is the patients with COVID-19, and asymptomatic 2019-nCoV carriers seem also a potential source of infection.

      2.2 Route of Transmission

      COVID-19 is mainly transmitted by droplets and contact. Aerosol transmission is possible when people have prolonged exposure to high concentrations of aerosols in relatively closed spaces.

      2.3

      Enjoying the preview?
      Page 1 of 1